Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(4.12)
# 1,635
Out of 4,707 analysts
1271
Total ratings
54.9%
Success rate
4.6%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Sell | 11,500p | 11,876p | -3.17% | 195 | Sep 8, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 140.00 | CHF 111.80 | +25.22% | 139 | Sep 8, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | 2,000p | 1,797p | +11.33% | 173 | Sep 2, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 265.00 | kr 292.00 | -9.25% | 163 | Sep 2, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €95.00 | €74.70 | +27.18% | 146 | Sep 2, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,250 → kr 2,500 | kr 2,170 | +15.21% | 24 | Sep 1, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $140 | $98.66 | +41.90% | 33 | Aug 26, 2026 | |
| LON: 0QW0 argenx SE | Downgraded: Hold | €900.00 → €925.00 | €869.20 | +6.42% | 36 | Aug 25, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | CHF 350.50 | -3.00% | 141 | Jul 24, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Buy | kr 285.00 → kr 515.00 | kr 457.00 | +12.69% | 18 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 → $47 | $46.61 | +0.18% | 7 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 70.00 → CHF 65.00 | CHF 68.20 | -4.69% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.16 | - | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €285.00 → €295.00 | €206.95 | +42.55% | 25 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,007.07 | - | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €11.00 → €12.00 | €10.00 | n/a | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 → €14.00 | €10.36 | n/a | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 | €24.08 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $43.16 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 1.00 | CHF 5.13 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $140.33 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,123.91 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $5.19 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.75 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €124.00 | €159.20 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $54.07 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.53 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €44.00 | €51.95 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $128 → $58 | $27.63 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $48.54 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $22.10 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €80.00 | €49.41 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €61.89 → €78.00 | €134.60 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $137.70 | n/a | 4 | Dec 7, 2018 |
AstraZeneca PLC
Sep 8, 2026
Maintained: Sell
Price Target: 11,500p
Current: 11,876p
Upside: -3.17%
Novartis AG
Sep 8, 2026
Maintained: Sell
Price Target: CHF 140.00
Current: CHF 111.80
Upside: +25.22%
GSK plc
Sep 2, 2026
Maintained: Hold
Price Target: 2,000p
Current: 1,797p
Upside: +11.33%
Novo Nordisk A/S
Sep 2, 2026
Maintained: Sell
Price Target: kr 265.00
Current: kr 292.00
Upside: -9.25%
Sanofi
Sep 2, 2026
Maintained: Buy
Price Target: €95.00
Current: €74.70
Upside: +27.18%
Genmab A/S
Sep 1, 2026
Maintained: Buy
Price Target: kr 2,250 → kr 2,500
Current: kr 2,170
Upside: +15.21%
BioNTech SE
Aug 26, 2026
Maintained: Buy
Price Target: $140
Current: $98.66
Upside: +41.90%
argenx SE
Aug 25, 2026
Downgraded: Hold
Price Target: €900.00 → €925.00
Current: €869.20
Upside: +6.42%
Roche Holding AG
Jul 24, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: CHF 350.50
Upside: -3.00%
Swedish Orphan Biovitrum AB (publ)
Jul 21, 2026
Maintained: Buy
Price Target: kr 285.00 → kr 515.00
Current: kr 457.00
Upside: +12.69%
Jun 4, 2026
Maintained: Hold
Price Target: $43 → $47
Current: $46.61
Upside: +0.18%
Apr 30, 2026
Maintained: Hold
Price Target: CHF 70.00 → CHF 65.00
Current: CHF 68.20
Upside: -4.69%
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $45.16
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: €285.00 → €295.00
Current: €206.95
Upside: +42.55%
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $1,007.07
Upside: -
Aug 5, 2025
Maintained: Hold
Price Target: €11.00 → €12.00
Current: €10.00
Upside: n/a
Jul 28, 2025
Maintained: Buy
Price Target: €12.00 → €14.00
Current: €10.36
Upside: n/a
Apr 28, 2025
Maintained: Hold
Price Target: €22.00
Current: €24.08
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $43.16
Upside: n/a
Nov 29, 2024
Maintained: Hold
Price Target: CHF 1.00
Current: CHF 5.13
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $140.33
Upside: n/a
Jul 17, 2024
Maintained: Hold
Price Target: n/a
Current: $1,123.91
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $5.19
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $7.75
Upside: n/a
Aug 7, 2023
Maintained: Hold
Price Target: €95.00 → €124.00
Current: €159.20
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $54.07
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $33.53
Upside: n/a
Aug 9, 2022
Maintained: Hold
Price Target: €44.00
Current: €51.95
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $128 → $58
Current: $27.63
Upside: n/a
Apr 16, 2021
Maintained: Sell
Price Target: n/a
Current: $48.54
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $22.10
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: €80.00
Current: €49.41
Upside: n/a
Jan 15, 2019
Maintained: Sell
Price Target: €61.89 → €78.00
Current: €134.60
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $137.70
Upside: n/a